Priscilla Borrego
Psychiatry · Cutler Bay, FLNPI 1346231768
Payments from drug & device makers
Across 809 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Teva Pharmaceuticals USA, Inc.$3K
- Otsuka America Pharmaceutical, Inc.$2K
- Johnson & Johnson$1K
- Alkermes, Inc.$1K
- Sunovion Pharmaceuticals Inc.$972
- plus $5K from 18 others
What the payments were for
- Travel & lodging$1,1106%
- Food & beverage$16,01993%
- Education$800%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 177 | $4,372 |
| Teva Pharmaceuticals USA, Inc. | 140 | $2,581 |
| Otsuka America Pharmaceutical, Inc. | 93 | $2,045 |
| Johnson & Johnson | 52 | $1,043 |
| Alkermes, Inc. | 47 | $1,016 |
| Sunovion Pharmaceuticals Inc. | 76 | $972 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $887 |
| Neurocrine Biosciences, Inc. | 39 | $854 |
| Lundbeck LLC | 40 | $769 |
| E.r. Squibb & Sons, L.L.C. | 21 | $635 |
| Indivior Inc. | 24 | $477 |
| Axsome Therapeutics, Inc. | 15 | $455 |
| Almatica Pharma LLC | 15 | $323 |
| Vanda Pharmaceuticals Inc. | 14 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $179 |
| Ironshore Pharmaceuticals Inc. | 5 | $89 |
| Noven Therapeutics, LLC | 3 | $69 |
| Viiv Healthcare Company | 1 | $29 |
| Tonix Medicines, Inc. | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| EMD Serono, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,208 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 17 | $222,821 |
| AustedoDeutetrabenazine | 24 | $182,889 |
| IngrezzaValbenazine Tosylate | 22 | $139,353 |
| Abilify MaintenaAripiprazole | 50 | $138,765 |
| AristadaAripiprazole Lauroxil | 45 | $137,970 |
| VraylarCariprazine Hcl | 84 | $112,443 |
| Invega SustennaPaliperidone Palmitate | 28 | $80,490 |
| RexultiBrexpiprazole | 41 | $61,831 |
| TrintellixVortioxetine Hydrobromide | 51 | $28,035 |
| Aripiprazole | 259 | $19,731 |
| Quetiapine Fumarate | 803 | $10,070 |
| Lurasidone Hcl | 65 | $9,507 |
| Buspirone Hcl | 939 | $8,988 |
| Mirtazapine | 632 | $6,659 |
| Trifluoperazine Hcl | 103 | $4,285 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo | $2,581 | $405,71041 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $2,045 | $200,59691 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $854 | $139,35322 claims |
| Alkermes, Inc.Aristada | $1,016 | $137,97045 claims |
| AbbVieVraylar | $4,372 | $112,44384 claims |
| Johnson & JohnsonInvega Sustenna | $1,043 | $80,49028 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $179 | $28,03551 claims |
| Almatica Pharma LLCSertraline Hcl | $323 | $1,192209 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Cutler Bay
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.